Thyrocare Technologies

1,068.40
-3.70
(-0.35%)
ann
There are new updates from the company22 hours ago
Viewcross
right
Market Cap
5,661.93 Cr
EPS
17.13
PE Ratio
62.26
Dividend Yield
1.95 %
52 Week High
1,085.00
52 Week Low
621.00
PB Ratio
10.42
Debt to Equity
0.06
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,880.00
#1 24,127.35
48.92
#1 2,554.80
11.28
#1 492
81.24
53.16
1,002.00
10,289.25
72.14
681.39
20.11
152
3.56
65.15
1,866.00
9,666.23
66.39
1,331.20
4.59
142
-20.00
63.94
1,068.40
#4 5,661.93
#7 62.26
#5 687.35
#8 8.63
#4 98
#4 25.58
58.44
779.45
2,516.83
30.79
717.16
25.65
81
10.70
59.17
320.20
1,667.63
52.91
252.09
14.77
31
14.29
47.92
1,599.00
1,372.36
29.06
96.47
25.47
49
-9.09
53.43
280.05
890.85
#1 9.47
1,110.95
35.04
-197
-18.52
50.46
280.10
547.39
28.63
147.04
#1 248.07
18
#1 175.00
54.82
182.00
126.75
83.40
41.78
6.34
1
28.57
66.97
Forecast
Actual
Growth Rate
Revenue Growth
8.63 %
Net Income Growth
7.92 %
Cash Flow Change
29.63 %
ROE
9.57 %
ROCE
10.57 %
EBITDA Margin (Avg.)
5.21 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
329
410
438
479
475
471
546
608
633
644
693
Fixed Assets
196
259
259
299
294
269
253
285
294
306
203
Current Assets
111
134
150
142
136
152
240
270
273
279
338
Capital Work in Progress
6
1
17
0
2
5
8
3
2
3
14
Investments
84
92
104
120
95
90
126
146
144
162
47
Other Assets
43
58
58
60
84
107
159
174
193
173
0
Total Liabilities
329
410
438
479
475
471
546
608
633
644
693
Current Liabilities
7
31
18
20
21
82
95
65
77
91
122
Non Current Liabilities
10
13
12
15
19
23
23
17
20
26
24
Total Equity
312
366
408
443
435
367
427
527
535
528
547
Reserve & Surplus
226
312
354
390
382
314
374
474
463
440
494
Share Capital
51
54
54
54
53
53
53
53
53
53
53

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
5
-1
-0
-5
4
5
0
4
-9
Investing Activities
-18
-18
-42
-43
-12
1
-49
-24
-39
-91
Operating Activities
35
68
90
107
100
168
115
113
129
168
Financing Activities
-23
-45
-49
-64
-94
-165
-62
-89
-86
-85

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
66.14 %
66.14 %
71.22 %
71.18 %
71.18 %
71.18 %
71.14 %
71.14 %
71.14 %
71.14 %
71.14 %
71.11 %
71.11 %
71.11 %
71.11 %
71.06 %
71.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.46 %
0.00 %
2.90 %
2.49 %
1.93 %
2.77 %
2.41 %
DIIs
7.14 %
6.17 %
6.07 %
6.37 %
6.52 %
6.68 %
8.66 %
8.69 %
8.45 %
13.46 %
13.33 %
13.55 %
14.88 %
14.90 %
14.80 %
14.67 %
14.97 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.01 %
6.32 %
7.60 %
7.44 %
6.65 %
6.71 %
7.28 %
8.07 %
8.38 %
9.42 %
9.66 %
9.15 %
8.48 %
8.66 %
9.78 %
9.16 %
9.21 %
Others
21.71 %
21.37 %
15.11 %
15.01 %
15.66 %
15.43 %
12.91 %
12.10 %
12.03 %
5.97 %
2.42 %
6.19 %
2.63 %
2.84 %
2.38 %
2.33 %
2.36 %
No of Share Holders
0
44,722
53,140
62,936
65,769
66,315
66,431
71,412
74,386
76,292
72,000
68,844
64,823
61,636
59,377
56,666
57,403

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 10 10 20 5 25 15 18 18 0.00
Dividend Yield (%) 0.00 1.68 1.87 4.03 0.55 3.22 3.56 3.05 2.65 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 1,020.40 1,072.10
25 Jul 2025 DIVIDEND Dividend
₹ 21.00 /share
25 Jul 2025 769.20 1,072.10
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Apr 2025 713.40 769.20
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 814.40 816.30
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 887.55 908.50
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 810.80 898.40
16 Aug 2024 DIVIDEND Dividend
₹ 18.00 /share
16 Aug 2024 647.25 881.55
20 Apr 2023 DIVIDEND Dividend
₹ 18.00 /share
20 Apr 2023 446.85 470.90
12 May 2022 DIVIDEND Dividend
₹ 15.00 /share
11 May 2022 812.25 734.95
19 Jun 2021 DIVIDEND Dividend
₹ 15.00 /share
17 Jun 2021 1,063.95 1,287.65

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication22 hours ago
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20152 days ago
Business Responsibility and Sustainability Reporting (BRSR)2 days ago
Intimation Of Record Date For Dividend2 days ago
Reg. 34 (1) Annual Report.2 days ago
Notice Convening 25Th Annual General Meeting Of The Company.2 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20157 days ago
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 03, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 21, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptApr 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 24, 2025
Audio Recordings Of Earnings Conference Call For The Quarter And Year Ended March 31 2025.Apr 23, 2025
Appointment Of Secretarial Auditors And Re-Appointment Of Cost AuditorApr 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationApr 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 23, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 23, 2025
Financial Results For Quarter And Year Ended March 31 2025 And Recommendation Of Final DividendApr 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On April 23 2025Apr 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 15, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of The Final Dividend If Any For The Financial Year 2024-25.Apr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2025
Integrated Filing (Financial)Feb 03, 2025
Updated Limited Review Report On The Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 23, 2025
Appointment of Company Secretary and Compliance OfficerJan 23, 2025
Announcement under Regulation 30 (LODR)-RetirementJan 23, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJan 23, 2025
Financial Results For Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and nine months ended December 31 2024Jan 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 16, 2025
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024.Jan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 09, 2025
Intimation Of Change In Name Of Registrar And Share Transfer Agent (RTA).Jan 01, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 10, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 09, 2024
Disclosure Under Regulation 30 - Equity Infusion In Thyrocare Laboratories (Tanzania) Limited - Joint VentureDec 03, 2024

Technical Indicators

RSI(14)
Neutral
66.37
ATR(14)
Volatile
37.89
STOCH(9,6)
Neutral
63.01
STOCH RSI(14)
Overbought
93.90
MACD(12,26)
Bullish
3.30
ADX(14)
Weak Trend
18.37
UO(9)
Bearish
59.01
ROC(12)
Uptrend And Accelerating
6.67
WillR(14)
Overbought
-9.86